We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+2.31%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$5.5B
AUM Growth
+$58M
Cap. Flow
-$11.2M
Cap. Flow %
-0.2%
Top 10 Hldgs %
36.95%
Holding
821
New
51
Increased
87
Reduced
185
Closed
82

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$25.4M
2
AMZN icon
Amazon
AMZN
+$17.1M
3
ROP icon
Roper Technologies
ROP
+$14.2M
4
TEL icon
TE Connectivity
TEL
+$12.1M
5
MSFT icon
Microsoft
MSFT
+$9.04M

Sector Composition

Rank Sector Weight
1 Technology 27.8%
2 Healthcare 17.78%
3 Financials 10.19%
4 Consumer Staples 9.56%
5 Consumer Discretionary 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAC icon
501
Camden National
CAC
$990M
$27K ﹤0.01%
600
CRSP icon
502
CRISPR Therapeutics
CRSP
$5.22B
$27K ﹤0.01%
600
PHX
503
DELISTED
PHX Minerals
PHX
$27K ﹤0.01%
1,405
VNQI icon
504
Vanguard Global ex-US Real Estate ETF
VNQI
$3.53B
$27K ﹤0.01%
435
ABB
505
DELISTED
ABB Ltd
ABB
$27K ﹤0.01%
1,150
SHPG
506
DELISTED
Shire pic
SHPG
$27K ﹤0.01%
181
COMT icon
507
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
$1.23B
$26K ﹤0.01%
+692
New +$25.5K
IFN
508
Aberdeen India Fund
IFN
$509M
$26K ﹤0.01%
1,069
IGSB icon
509
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
$26K ﹤0.01%
+500
New +$26K
MTRN icon
510
Materion
MTRN
$5.9B
$26K ﹤0.01%
500
CATC
511
DELISTED
CAMBRIDGE BANCORP
CATC
$26K ﹤0.01%
300
-750
-71% -$61.2K
SGEN
512
DELISTED
Seagen Inc. Common Stock
SGEN
$26K ﹤0.01%
505
AKAM icon
513
Akamai
AKAM
$17.6B
$25K ﹤0.01%
350
EMB icon
514
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
$25K ﹤0.01%
+224
New +$25.4K
ISTB icon
515
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.13B
$25K ﹤0.01%
+498
New +$24.6K
WDAY icon
516
Workday
WDAY
$43.3B
$25K ﹤0.01%
200
WOLF icon
517
Wolfspeed
WOLF
$1.65B
$25K ﹤0.01%
630
BB icon
518
BlackBerry
BB
$5.14B
$24K ﹤0.01%
+2,053
New +$26.1K
EFAV icon
519
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.46B
$24K ﹤0.01%
+319
New +$23.5K
TLT icon
520
iShares 20+ Year Treasury Bond ETF
TLT
$40.6B
$24K ﹤0.01%
+193
New +$23.3K
VOO icon
521
Vanguard S&P 500 ETF
VOO
$1.03T
$24K ﹤0.01%
98
AVAV icon
522
AeroVironment
AVAV
$9.81B
$23K ﹤0.01%
500
RWO icon
523
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.28B
$23K ﹤0.01%
500
KMI icon
524
Kinder Morgan
KMI
$70.7B
$22K ﹤0.01%
1,430
LBRDA icon
525
Liberty Broadband Class A
LBRDA
$5.07B
$22K ﹤0.01%
262

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, Loring Wolcott & Coolidge Fiduciary Advisors held 821 positions worth $5.5B, up 1.1% from $5.45B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2018 filing shows 51 new, 87 increased, 185 reduced and 82 closed positions. Its largest new stake was Diamondback Energy: 3,285 shares worth $416K. The largest sale was Novo Nordisk, an estimated $11.6M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q1 2018 buy was Diamondback Energy: 3,285 shares worth $416K.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Becton Dickinson in Q1 2018, an estimated $25.4M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q1 2018 reduction was Novo Nordisk, cutting an estimated $11.6M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $229K.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 37% of its $5.5B portfolio in Q1 2018.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 51 new positions and closed 82 in Q1 2018.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 1.1% quarter-over-quarter to $5.5B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2018, filed 20 Apr 2018.